100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Ranowin 1000mg Tablet ER
Innovative Pharmaceuticals
₹189.5
Our Recommendation
Ranogem 1000mg Tablet ER 10s
840+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Angina (heart-related chest pain)
Customers also bought
More About Ranowin 1000mg Tablet ER
Benefits
In Treatment of Angina (heart-related chest pain)Ranowin 1000mg Tablet ER reduces the oxygen requirement of the heart and relaxes the heart muscles. It makes sure that your heart is able to perform its functions in the amount of oxygen supply available without causing stress on heart muscles. This makes it less likely that you will suffer chest pain caused by angina. This medicine can help increase your ability to exercise and go about your daily life more easily by reducing the frequency of angina attacks. You should take it regularly and as long as it is prescribed for it to work effectively.
Side Effects
Side effects of Ranowin Tablet ERThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Ranowin Nausea Vomiting Headache Dizziness Constipation Weakness
How to use
How to use Ranowin Tablet ERFollow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Ranowin 1000mg Tablet ER is to be taken with food.
How it works
How Ranowin Tablet ER works Ranowin 1000mg Tablet ER is an anti-anginal medication. It works by decreasing the oxygen requirement of the heart by relaxing heart muscle.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Ranowin 1000mg Tablet ER . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Ranowin 1000mg Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Ranowin 1000mg Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
It is not known whether Ranowin 1000mg Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Ranowin 1000mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Ranowin 1000mg Tablet ER may be needed. Doctor consultation is advised.Use of Ranowin 1000mg Tablet ER is not recommended in patients with severe kidney disease.
Ranowin 1000mg Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Ranowin 1000mg Tablet ER may be needed. Doctor consultation is advised.Use of Ranowin 1000mg Tablet ER is not recommended in patients with moderate to severe liver disease.
What if I forget to take it?
If a dose of Ranowin 1000mg Tablet ER is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
501, Pearl Arcade, J.P.Road, Andheri (West), Mumbai-58, (Mahrashtra) INDIA
References
Opie LH, Horowitz JD. Nitrates and Newer Antianginals ?-Blocking Agents. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 56
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1200
Ranolazine. Wooburn Green, Buckinghamshire: A. Menarini Farmaceutica Internazionale SRL; 2008 (25 Jan. 2019)
Ranolazine. Foster City, California: Gilead Sciences, Inc.; 2013 (20 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Ranolazine Sustained Release Tablets (25 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
